FIFA, May 10 / PRNewswire-FirstCall-Asianet /-- 14 departments, including the Health Commission, jointly issued a circular on correcting unhealthy tendencies in the field of pharmaceutical purchase and sale and medical services in 2023. The circular mentions strengthening the standardized management and use of medical insurance funds. Focus on key departments, key areas, focus on monitoring drugs and drug consumables with top medical insurance settlement costs, and standardize the management and use of medical insurance funds. We will continue to crack down on fraudulent and fraudulent insurance practices such as fake medical treatment and resale of medical insurance drugs. Continue to promote pharmaceutical prices and recruitment credit evaluation. We should further strengthen information sharing with relevant departments, evaluate the dishonesty level of pharmaceutical enterprises according to the facts of pharmaceutical commercial bribery, monopoly and other cases recognized by judicial organs and administrative departments, and take varying degrees of disposal and restraint measures such as credit risk warning and restrictions on hanging up the net, so as to give full play to the guiding and binding role of the pharmaceutical centralized procurement market.